My bookmarksSign up free
Source

2011/73/EU: Commission Decision of 2 February 2011 authorising the placing on the market of a mycelial extract from Lentinula edodes (Shiitake mushroom) as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2011) 442)

2011/73/EU: Commission Decision of 2 February 2011 authorising the placing on the market of a mycelial extract from Lentinula edodes (Shiitake mushroom) as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2011) 442)

Regulation (EC) No 258/97 · Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The mycelial extract from Lentinula edodes as specified in Annex I may be placed on the market in the Union as a novel food ingredient for the uses listed in Annex II.

Article 2

Open ↗

The designation of the mycelial extract from Lentinula edodes authorised by this Decision on the labelling of the foodstuff containing it shall be ‘extract from the mushroom Lentinula edodes ’ or ‘extract from the Shiitake mushroom’.

Article 3

Open ↗

This Decision is addressed to GlycaNova Norge AS, Oraveien 2, 1630 Gamle Fredrikstad, Norway.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I Specifications of the mycelial extract from Lentinula edodes Description: The novel food ingredient is a sterile aqueous extract obtained from the mycelium of Lentinula edodes cultivated in a submerged fermentation. It is a light brown, slightly turbid liquid. Lentinan is a β-(1-3) β-(1-6)-D-glucan which has a molecular weight of approximately 5 × 10 5 Daltons, a degree of branching of 2/5 and a triple helical tertiary structure. Composition of the mycelial extract from Lentinula edodes Moisture 98  % Dry matter 2  % Free glucose less than 20 mg/ml Total Protein  ( *1 ) less than 0,1 mg/ml N-containing constituents  ( *2 ) less than 10 mg/ml Lentinan 0,8 – 1,2 mg/ml ( *1 )   Bradford method ( *2 )   Kjeldahl method

ANNEX IISupplementary provisions

Open ↗

ANNEX II Uses of the mycelial extract from Lentinula edodes Use group Maximum level of mycelial extract from Lentinula edodes Bread products 2 ml/100 g Soft drinks 0,5 ml/100 ml Ready prepared meals 2,5 ml per meal Foods based on yoghurt 1,5 ml/100 ml Food supplements (as defined in Directive 2002/46/EC  ( 1 ) ) 2,5 ml per day dose ( 1 )    OJ L 183, 12.7.2002, p. 51 .

Other acts of the same type
Council Decision (EU) 2026/2240 of 24 September 2026 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Annex XX (Environment) to the EEA Agreement (CBAM) (Text with EEA relevance)Council Decision (EU) 2026/2255 of 24 September 2026 on the position to be adopted on behalf of the European Union within the EEA Joint Committee concerning the amendment of Annex IV (Energy) to the EEA Agreement (Network Code on Gas Balancing of Transmission Networks) (Text with EEA relevance)Council Decision (EU) 2026/2256 of 24 September 2026 on the position to be adopted on behalf of the European Union within the EEA Joint Committee concerning the amendment of Protocol 10 to the EEA Agreement, on simplification of inspections and formalities in respect of carriage of goods, and Protocol 31 to the EEA Agreement, on cooperation in specific fields outside the four freedoms (CBAM financial contribution) (Text with EEA relevance)Commission Implementing Decision (EU) 2026/2112 of 23 September 2026 authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean GMB151 × DAS-44406-6 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2026) 6604)Commission Implementing Decision (EU) 2026/2117 of 23 September 2026 authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 94313 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2026) 6606)Commission Implementing Decision (EU) 2026/2119 of 23 September 2026 postponing the expiry date of the approval of K-HDO for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2026/2121 of 23 September 2026 renewing the authorisation for placing on the market of products containing, consisting of or produced from genetically modified maize MON 87460 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2026) 6605)Council Decision of 22 September 2026 replacing a member of the Advisory Committee for the Coordination of Social Security Systems for AustriaCouncil Decision of 22 September 2026 replacing a member of the Advisory Committee for the Coordination of Social Security Systems for FranceCouncil Decision of 22 September 2026 appointing members and alternate members of the Advisory Committee on freedom of movement for workersCouncil Decision of 22 September 2026 replacing an alternate member of the Management Board of the European Centre for the Development of Vocational Training (Cedefop) for the NetherlandsCouncil Decision of 22 September 2026 replacing an alternate member of the Management Board of the European Foundation for the improvement of living and working conditions for Germany

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next